Skip to content

Parent-child interaction therapy for aggression in children of caregiver with cancer, a double-blind randomized controlled trial

Parent-child interaction therapy for aggression in children of caregiver with cancer, a double-blind randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190121001
Enrollment
50
Registered
2019-01-21
Start date
2015-03-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All stages of the research were performed after obtaining informed written consent from the parents and the verbal consent of the child and based on the latest version of Helsinki Declaration. Parent&#45

Interventions

PCIT Protocol (UC Davis PCIT Training Center&#44
Sacramento) was conducted in two phases of child directed interaction (to improve communication) and parent directed interaction (to practice interactive discipline) in twelve sessions. ,In the contro
a combination of motivational enhancement therapy (MET) and cognitive&#45
behavioral therapy (CBT) was presented&#44
so that there was no difference between the two groups.
child interaction therapy (PCIT) ,motivational enhancement therapy (MET)

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 7 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were: 1) age range of 5-7 years in children; 2) the diagnosis of metastatic cancer stage 4 in at least one parent or caregiver; 3) the diagnosis of dependence to cannabis with a given dose by caregiver; 4) the diagnosis of aggression syndrome in two clinical domains and evaluation of questionnaires

Exclusion criteria

Exclusion criteria: The exclusion criteria for mothers and children were as follow: 1) lack of natural intelligence with a criterion of less than 70; 2) use of psychiatric medications due to the possible effect on the psychological syndrome.

Design outcomes

Primary

MeasureTime frame
children's aggression 12 weeks aggression scale

Secondary

MeasureTime frame
level of salivary cortisol 12 weeks ELISA kits

Countries

iran

Contacts

Public Contactbijan pirnia

Bijan Center

b.pirnia@usc.ac.ir+9802122081450

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026